{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T04:13:25Z","timestamp":1748405605446,"version":"3.41.0"},"reference-count":59,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,27]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Hemophagocytic lymphohistiocytosis (HLH) is a rare but aggressive and potentially lethal hyperinflammatory syndrome characterized by pathologic immune activation and excessive production of proinflammatory cytokines leading to tissue damage and multisystem organ failure. There is an urgent need for the discovery of novel targets and development of therapeutic strategies to treat this rare but deadly syndrome. Protein arginine methyltransferase 5 (PRMT5) mediates T-cell\u2013based inflammatory responses, making it a potential actionable target for the treatment of HLH. Using CPG-1826 and anti\u2013interleukin-10R (IL-10R) antibody, we induced murine secondary HLH in vivo with a marked expansion of splenic myeloid cell subsets and concurrent reduction of T- and natural killer (NK)\u2013cell populations. PRMT5 expression was significantly upregulated in splenic T and NK lymphocytes, monocytes, and dendritic cells in mice with HLH (P &amp;lt; .05). Treatment with PRT382, a potent and selective PRMT5 inhibitor, significantly reduced physical signs of secondary HLH, including splenomegaly, hepatomegaly, and anemia (P &amp;lt; .0001 in each case), when compared with untreated mice. Inflammatory cytokines known to drive hyperinflammation in HLH, including interferon-\u03b3 and IL-6 were reduced to healthy levels with PRT382 treatment (P &amp;gt; .999 for both). PRT382 treatment also reduced the expansion of myeloid cell populations (P &amp;lt; .0001) in mice with HLH, compared with untreated mice, while restoring T- and NK-cell numbers (P &amp;lt; .001 for both). These results identify PRMT5 as a promising target for the management of secondary HLH and justify further exploration in this and other models of hyperinflammation.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024013651","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T14:57:09Z","timestamp":1737212229000},"page":"2379-2392","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["PRMT5 inhibition reduces hyperinflammation in a murine model of secondary hemophagocytic lymphohistiocytosis"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6692-8678","authenticated-orcid":false,"given":"Fiona","family":"Brown-Burke","sequence":"first","affiliation":[{"name":"1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Saadey","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiao-Yin Charlene","family":"Mao","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Marra","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Brooks","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexa","family":"Wandtke","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Hout","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sydney","family":"Leon","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archisha","family":"Sharma","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aneeq","family":"Yasin","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor","family":"Cash","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2525-7123","authenticated-orcid":false,"given":"Elshafa Hassan","family":"Ahmed","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH"},{"name":"2Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan","family":"Baiocchi","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Finoti","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Zhang","sequence":"additional","affiliation":[{"name":"3Department of Biomedical Informatics, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neha","family":"Bhagwat","sequence":"additional","affiliation":[{"name":"4Prelude Therapeutics, Wilmington, DE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kris","family":"Vaddi","sequence":"additional","affiliation":[{"name":"4Prelude Therapeutics, Wilmington, DE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peggy","family":"Scherle","sequence":"additional","affiliation":[{"name":"4Prelude Therapeutics, Wilmington, DE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Mozhenkova","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikbale","family":"El-Ayachi","sequence":"additional","affiliation":[{"name":"5Division of Transplantation Surgery, The Ohio State University Wexner Medical, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4877-1042","authenticated-orcid":false,"given":"Austin D.","family":"Schenk","sequence":"additional","affiliation":[{"name":"5Division of Transplantation Surgery, The Ohio State University Wexner Medical, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelby L.","family":"Sloan","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH"},{"name":"2Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaylee","family":"Whitman","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JoBeth","family":"Helmig-Mason","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheldon","family":"Steyn","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0885-0029","authenticated-orcid":false,"given":"Haley L.","family":"Klimaszewski","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3781-4521","authenticated-orcid":false,"given":"Jessica","family":"Weist","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Weigel","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirsha","family":"Koirala","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lapo","family":"Alinari","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katiri","family":"Snyder","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parvathi","family":"Ranganathan","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9860-4328","authenticated-orcid":false,"given":"Chia-Jo","family":"Chen","sequence":"additional","affiliation":[{"name":"6Department of Pediatrics, University of Cincinnati, Cincinnati, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael B.","family":"Jordan","sequence":"additional","affiliation":[{"name":"6Department of Pediatrics, University of Cincinnati, Cincinnati, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1619-4853","authenticated-orcid":false,"given":"Robert A.","family":"Baiocchi","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6543-0050","authenticated-orcid":false,"given":"Polina","family":"Shindiapina","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"2025052708370634800_bib1","first-page":"69","article-title":"Hemophagocytic lymphohistiocytosis: review of etiologies and management","volume":"5","author":"George","year":"2014","journal-title":"Hematol Res Rev"},{"issue":"1","key":"2025052708370634800_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/10428194.2018.1482543","article-title":"Hemophagocytic lymphohistiocytosis in adults","volume":"60","author":"Bhatt","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"9927","key":"2025052708370634800_bib3","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"2025052708370634800_bib4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1586\/eci.09.58","article-title":"Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy","volume":"6","author":"Gupta","year":"2010","journal-title":"Expet Rev Clin Immunol"},{"issue":"4","key":"2025052708370634800_bib5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/bjh.17662","article-title":"Hemophagocytic lymphohistiocytosis-like toxicity (carHLH) after CD19-specific CAR T-cell therapy","volume":"194","author":"Hines","year":"2021","journal-title":"Br J Haematol"},{"issue":"5","key":"2025052708370634800_bib6","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/CCM.0000000000005361","article-title":"Consensus-based guidelines for the recognition, diagnosis, and management of hemophagocytic lymphohistiocytosis in critically ill children and adults","volume":"50","author":"Hines","year":"2022","journal-title":"Crit Care Med"},{"issue":"19","key":"2025052708370634800_bib7","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1182\/blood-2015-01-551622","article-title":"How I treat hemophagocytic lymphohistiocytosis in the adult patient","volume":"125","author":"Schram","year":"2015","journal-title":"Blood"},{"issue":"10","key":"2025052708370634800_bib8","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1002\/1097-0142(19800515)45:10<2516::AID-CNCR2820451008>3.0.CO;2-V","article-title":"Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP 16-213","volume":"45","author":"Ambruso","year":"1980","journal-title":"Cancer"},{"issue":"19","key":"2025052708370634800_bib9","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMoa1911326","article-title":"Emapalumab in children with primary hemophagocytic lymphohistiocytosis","volume":"382","author":"Locatelli","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"2025052708370634800_bib10","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41409-022-01634-5","article-title":"Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT","volume":"57","author":"Machowicz","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"19","key":"2025052708370634800_bib11","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.3390\/jcm11195799","article-title":"Anakinra for the treatment of hemophagocytic lymphohistiocytosis: 21 cases","volume":"11","author":"Baverez","year":"2022","journal-title":"J Clin Med"},{"issue":"10","key":"2025052708370634800_bib12","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1182\/blood.2023020578","article-title":"Immune effector cell-associated hematotoxicity: EHA\/EBMT consensus grading and best practice recommendations","volume":"142","author":"Rejeski","year":"2023","journal-title":"Blood"},{"issue":"1","key":"2025052708370634800_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12969-019-0309-6","article-title":"Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome","volume":"17","author":"Halyabar","year":"2019","journal-title":"Pediatr Rheumatol Online J"},{"issue":"12","key":"2025052708370634800_bib14","doi-asserted-by":"crossref","first-page":"e630","DOI":"10.1016\/S2352-3026(19)30156-5","article-title":"Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial","volume":"6","author":"Ahmed","year":"2019","journal-title":"Lancet Haematol"},{"issue":"17","key":"2025052708370634800_bib15","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1182\/blood-2011-06-356261","article-title":"Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol","volume":"118","author":"Trottestam","year":"2011","journal-title":"Blood"},{"issue":"7","key":"2025052708370634800_bib16","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1182\/blood.2021012764","article-title":"An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis","volume":"139","author":"Zoref-Lorenz","year":"2022","journal-title":"Blood"},{"issue":"35","key":"2025052708370634800_bib17","doi-asserted-by":"crossref","first-page":"32971","DOI":"10.1074\/jbc.M105412200","article-title":"PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins","volume":"276","author":"Branscombe","year":"2001","journal-title":"J Biol Chem"},{"issue":"12","key":"2025052708370634800_bib18","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/ncb1802","article-title":"Arginine methylation regulates the p53 response","volume":"10","author":"Jansson","year":"2008","journal-title":"Nat Cell Biol"},{"issue":"15","key":"2025052708370634800_bib19","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1093\/nar\/gkp516","article-title":"PRMT5 is required for cell-cycle progression and p53 tumor suppressor function","volume":"37","author":"Scoumanne","year":"2009","journal-title":"Nucleic Acids Res"},{"issue":"33","key":"2025052708370634800_bib20","doi-asserted-by":"crossref","first-page":"13516","DOI":"10.1073\/pnas.1311784110","article-title":"PRMT5 dimethylates R30 of the p65 subunit to activate NF-\u03baB","volume":"110","author":"Wei","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"2025052708370634800_bib21","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1182\/blood-2014-12-619783","article-title":"Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation","volume":"125","author":"Alinari","year":"2015","journal-title":"Blood"},{"issue":"19","key":"2025052708370634800_bib22","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1182\/blood-2018-02-831438","article-title":"PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survival","volume":"132","author":"Lu","year":"2018","journal-title":"Blood"},{"issue":"12","key":"2025052708370634800_bib23","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1038\/s41375-019-0489-6","article-title":"PRMT5 is upregulated by B-cell receptor signaling and forms a positive-feedback loop with PI3K\/AKT in lymphoma cells","volume":"33","author":"Zhu","year":"2019","journal-title":"Leukemia"},{"issue":"19","key":"2025052708370634800_bib24","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.1074\/jbc.RA119.007640","article-title":"Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT\/\u03b2-catenin and AKT\/GSK3\u03b2 proliferative signaling","volume":"294","author":"Chung","year":"2019","journal-title":"J Biol Chem"},{"issue":"7","key":"2025052708370634800_bib25","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/emboj.2012.17","article-title":"Arginine methylation controls growth regulation by E2F-1","volume":"31","author":"Cho","year":"2012","journal-title":"EMBO J"},{"issue":"1","key":"2025052708370634800_bib26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molcel.2013.08.039","article-title":"Arginine methylation-dependent reader-writer interplay governs growth control by E2F-1","volume":"52","author":"Zheng","year":"2013","journal-title":"Mol Cell"},{"issue":"11","key":"2025052708370634800_bib27","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1158\/2159-8290.CD-20-0026","article-title":"PRMT5 inhibition modulates E2F1 methylation and gene-regulatory networks leading to therapeutic efficacy in JAK2V617F \u2013 mutant MPN","volume":"10","author":"Pastore","year":"2020","journal-title":"Cancer Discov"},{"key":"2025052708370634800_bib28","doi-asserted-by":"crossref","first-page":"865964","DOI":"10.3389\/fimmu.2022.865964","article-title":"Protein arginine methylation: an emerging modification in cancer immunity and immunotherapy","volume":"13","author":"Dai","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"2025052708370634800_bib29","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.4049\/jimmunol.1601702","article-title":"PRMT5-selective inhibitors suppress inflammatory T cell responses and experimental autoimmune encephalomyelitis","volume":"198","author":"Webb","year":"2017","journal-title":"J Immunol"},{"issue":"8","key":"2025052708370634800_bib30","doi-asserted-by":"crossref","first-page":"e131099","DOI":"10.1172\/jci.insight.131099","article-title":"PRMT5 regulates T cell interferon response and is a target for acute graft-versus-host disease","volume":"5","author":"Snyder","year":"2020","journal-title":"JCI Insight"},{"issue":"2","key":"2025052708370634800_bib31","doi-asserted-by":"crossref","first-page":"e0148905","DOI":"10.1371\/journal.pone.0148905","article-title":"PRMT5-mediated methylation of NF-\u03baB p65 at Arg174 is required for endothelial CXCL11 gene induction in response to TNF-\u03b1 and IFN-\u03b3 costimulation","volume":"11","author":"Harris","year":"2016","journal-title":"PLoS One"},{"issue":"22","key":"2025052708370634800_bib32","doi-asserted-by":"crossref","first-page":"15328","DOI":"10.1074\/jbc.M114.547349","article-title":"Tumor necrosis factor (TNF)-\u03b1 induction of CXCL10 in endothelial cells requires protein arginine methyltransferase 5 (PRMT5)-mediated nuclear factor (NF)-\u03baB p65 methylation","volume":"289","author":"Harris","year":"2014","journal-title":"J Biol Chem"},{"issue":"4","key":"2025052708370634800_bib33","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/jcmm.13020","article-title":"Role of protein arginine methyltransferase 5 in inflammation and migration of fibroblast-like synoviocytes in rheumatoid arthritis","volume":"21","author":"Chen","year":"2017","journal-title":"J Cell Mol Med"},{"issue":"1","key":"2025052708370634800_bib34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s13075-020-02304-x","article-title":"PRMT5 inhibition attenuates cartilage degradation by reducing MAPK and NF-\u03baB signaling","volume":"22","author":"Dong","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"2025052708370634800_bib35","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.4049\/jimmunol.2100994","article-title":"PRMT5 in T cells drives Th17 responses, mixed granulocytic inflammation, and severe allergic airway inflammation","volume":"208","author":"Lewis","year":"2022","journal-title":"J Immunol"},{"key":"2025052708370634800_bib36","doi-asserted-by":"crossref","first-page":"695947","DOI":"10.3389\/fimmu.2021.695947","article-title":"PRMT5 promotes cyclin E1 and cell cycle progression in CD4 Th1 cells and correlates with EAE severity","volume":"12","author":"Amici","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"2025052708370634800_bib37","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1172\/JCI131254","article-title":"Protein arginine methyltransferase 5 promotes cholesterol biosynthesis\u2013mediated Th17 responses and autoimmunity","volume":"130","author":"Webb","year":"2020","journal-title":"J Clin Invest"},{"issue":"6","key":"2025052708370634800_bib38","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.celrep.2020.01.054","article-title":"Symmetric arginine dimethylation is selectively required for mRNA splicing and the initiation of type I and type III interferon signaling","volume":"30","author":"Metz","year":"2020","journal-title":"Cell Rep"},{"issue":"3","key":"2025052708370634800_bib39","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3892\/etm.2021.10436","article-title":"Protein arginine methyltransferase 5 mediates THP-1-derived macrophage activation dependent on NF-\u03baB in endometriosis","volume":"22","author":"Chai","year":"2021","journal-title":"Exp Ther Med"},{"issue":"2","key":"2025052708370634800_bib40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1182\/blood.2019000761","article-title":"Mechanisms of action of ruxolitinib in murine models of hemophagocytic lymphohistiocytosis","volume":"134","author":"Albeituni","year":"2019","journal-title":"Blood"},{"issue":"7","key":"2025052708370634800_bib41","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/art.37958","article-title":"Interferon-\u03b3 mediates anemia but is dispensable for fulminant toll-like receptor 9-induced macrophage activation syndrome and hemophagocytosis in mice","volume":"65","author":"Canna","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2025052708370634800_bib42","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1172\/JCI43157","article-title":"Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice","volume":"121","author":"Behrens","year":"2011","journal-title":"J Clin Invest"},{"issue":"1","key":"2025052708370634800_bib43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41467-022-35778-1","article-title":"Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformation","volume":"14","author":"Hing","year":"2023","journal-title":"Nat Commun"},{"issue":"10","key":"2025052708370634800_bib44","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1182\/blood.2022019419","article-title":"PRMT5 supports multiple oncogenic pathways in mantle cell lymphoma","volume":"142","author":"Sloan","year":"2023","journal-title":"Blood"},{"issue":"20","key":"2025052708370634800_bib45","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.1182\/bloodadvances.2023009906","article-title":"PRMT5 inhibition drives therapeutic vulnerability to combination treatment with BCL-2 inhibition in mantle cell lymphoma","volume":"7","author":"Brown-Burke","year":"2023","journal-title":"Blood Adv"},{"issue":"13","key":"2025052708370634800_bib46","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood-2015-12-684399","article-title":"Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis","volume":"127","author":"Das","year":"2016","journal-title":"Blood"},{"issue":"4","key":"2025052708370634800_bib47","doi-asserted-by":"crossref","first-page":"101515","DOI":"10.1016\/j.berh.2020.101515","article-title":"Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy","volume":"34","author":"Griffin","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"22","key":"2025052708370634800_bib48","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","article-title":"Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages","volume":"127","author":"Emile","year":"2016","journal-title":"Blood"},{"issue":"3","key":"2025052708370634800_bib49","doi-asserted-by":"crossref","first-page":"58","DOI":"10.36401\/JIPO-22-1","article-title":"Protein arginine methyltransferase 5 (PRMT5) inhibitors in oncology clinical trials: a review","volume":"5","author":"Feustel","year":"2022","journal-title":"J Immunother Precis Oncol"},{"issue":"4","key":"2025052708370634800_bib50","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/leu.2015.308","article-title":"The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation","volume":"30","author":"Tarighat","year":"2016","journal-title":"Leukemia"},{"key":"2025052708370634800_bib51","doi-asserted-by":"crossref","first-page":"1093430","DOI":"10.3389\/fimmu.2022.1093430","article-title":"Editorial: The role of monocytes\/macrophages in autoimmunity and autoinflammation","volume":"13","author":"Kawakami","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"2025052708370634800_bib52","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","article-title":"An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder","volume":"104","author":"Jordan","year":"2004","journal-title":"Blood"},{"issue":"suppl 1","key":"2025052708370634800_bib53","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1182\/blood-2024-208866","article-title":"Targeting PRMT5 in primary hemophagocytic lymphohistiocytosis: a novel therapeutic approach using a perforin-deficient mouse model","volume":"144","author":"Steyn","year":"2024","journal-title":"Blood"},{"issue":"suppl 1","key":"2025052708370634800_bib54","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1182\/blood-2022-167988","article-title":"PRMT5 inhibition potentiates anti-tumor immune targeting of EBV-driven B cell lymphoproliferative disease","volume":"140","author":"Ahmed","year":"2022","journal-title":"Blood"},{"issue":"6","key":"2025052708370634800_bib55","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.20102538","article-title":"Hemophagocytosis causes a consumptive anemia of inflammation","volume":"208","author":"Zoller","year":"2011","journal-title":"J Exp Med"},{"issue":"1","key":"2025052708370634800_bib56","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/imm.13182","article-title":"CpG-ODN-mediated TLR9 innate immune signalling and calcium dyshomeostasis converge on the NF\u03baB inhibitory protein I\u03baB\u03b2 to drive IL1\u03b1 and IL1\u03b2 expression","volume":"160","author":"De Dios","year":"2020","journal-title":"Immunology"},{"issue":"3","key":"2025052708370634800_bib57","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0092-8674(00)81288-X","article-title":"Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway","volume":"84","author":"Meraz","year":"1996","journal-title":"Cell"},{"issue":"10","key":"2025052708370634800_bib58","doi-asserted-by":"crossref","first-page":"2003047","DOI":"10.1002\/advs.202003047","article-title":"PRMT5 enables robust STAT3 activation via arginine symmetric dimethylation of SMAD7","volume":"8","author":"Cai","year":"2021","journal-title":"Adv Sci"},{"issue":"1","key":"2025052708370634800_bib59","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jaci.2022.07.026","article-title":"Combined IFN-gamma and JAK inhibition to treat hemophagocytic lymphohistiocytosis in mice","volume":"151","author":"Joly","year":"2023","journal-title":"J Allergy Clin Immunol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/10\/2379\/2374441\/blooda_adv-2024-013651-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/10\/2379\/2374441\/blooda_adv-2024-013651-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T12:37:19Z","timestamp":1748349439000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/10\/2379\/535193\/PRMT5-inhibition-reduces-hyperinflammation-in-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":59,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,5,27]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024013651","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"type":"print","value":"2473-9529"},{"type":"electronic","value":"2473-9537"}],"subject":[],"published-other":{"date-parts":[[2025,5,27]]},"published":{"date-parts":[[2025,5,14]]}}}